Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of biogenic estrogen sulfamates for hormone replacement therapy

Use of biogenic estrogen sulfamates for hormone replacement therapy

US Patent 7053077 · Granted May 30, 2006

Estimated economic value: $2,191,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Progestogen-only oral contraception2025
Substituted dihydroquinazolines2023
Progestogen-only oral contraception2023
Pro-drug forming compounds2019
Substituted dihydroquinazolines2018
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Pro-drug forming compounds2017
Imidazolyl progesterone antagonists2015
Substituted dihydroquinazolines2013
Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes2013
Use of estradiol valerate or 17β-estradiol in combination with dienogest for ora2013
Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents2013